Malawi has approved the long-acting HIV drug lenacapavir after an expedited review, marking a major step in strengthening national HIV prevention efforts.
Malawi approves lenacapavir in major HIV breakthrough Read More »
Gilead has announced licensing deals to expand access to its HIV prevention drug, lenacapavir, in lower-income countries.
Gilead’s HIV prevention drug gets a boost from licensing deals Read More »
Over 300 politicians, health experts, and celebrities urge Gilead to make the drug affordable in developing countries.
Over 300 demand Gilead share HIV drug for developing countries Read More »
